Coronavirus Disease 2019 (COVID-19) vaccine by China National Biotec Group for Coronavirus Disease 2019 (COVID-19) Pneumonia: Likelihood of Approval

Coronavirus Disease 2019 (COVID-19) vaccine is under clinical development by China National Biotec Group and currently in Phase III for Coronavirus Disease 2019 (COVID-19) Pneumonia.

Older Immunocompromised Folks May Need More From RSV Vaccines

Immune responses to respiratory syncytial virus (RSV) vaccines tended to fall short in older people with weakened immunity, a study found. In 38 immunocompromised persons

January 1, 2025

Is managing emotions more effective than boosting wellbeing in curbing teens’ sweet tooth?

A recent study explored whether emotion-driven impulsiveness or psychosocial well-being contributes more to healthy or unhealthy food choices.

January 11, 2024

Medicare beneficiaries deserve access to genetic counselors

Precision medicine driven by genetic health care is knocking on the door. It offers hope that, sooner than later, we can address health problems like

August 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.